LCOR and breast cancer: Subsequently, using the same molecular inhibitors of ERα, we could restore the immunogenic function of LCOR in HR+ BC by increasing APM expression in MCF-7-LCOR–OE cells measured by flow cytometry and quantitative reverse transcription PCR (RT-qPCR) (Figure 4, A and B).